Skip to main content
. 2016 Feb 4;38(12):852–859. doi: 10.1093/eurheartj/ehv643
First choice Monotherapy with an NOAC is preferable for patients with AF and stable CAD. This suggestion is applicable to all NOACs
Second choice In selected patients, addition of aspirin is still indicated in the long-term, based on individual risk assessment and coronary anatomy
Comment In the absence of direct comparative studies, no particular NOAC can be favoured over another